Mounjaro, a new injectable medication, is gaining popularity for its effectiveness in weight loss. While it’s licensed to treat type 2 diabetes, its ability to mimic two hormones makes it more effective than Ozempic and Wegovy. However, the surge in demand for weight loss has led to shortages for diabetics, and experts warn about potential side effects and the importance of lifestyle changes.
Eli Lilly’s popular obesity and diabetes drugs, Mounjaro and Zepbound, are facing ongoing shortages that are limiting their supply and impacting the company’s earnings. According to analysts, these shortages could result in lower revenue and earnings per share for the first quarter. The company is working to ramp up manufacturing to meet the demand, but the impact on earnings remains a concern. Investors will be watching for updates on manufacturing capacity, pricing, and coverage decisions from insurers as they assess the impact on Lilly’s financial performance.
Women with infertility issues are getting pregnant while taking weight-loss medications Ozempic and Mounjaro, raising safety concerns during pregnancy. These GLP-1 drugs are mainly used to manage blood sugar levels in people with type 2 diabetes and for obesity treatment, but their impact on pregnancy is still largely unknown. Despite encouraging stories, experts emphasize the need for more data on the drugs’ safety and long-term effects on pregnancy outcomes, particularly in women without diabetes. Researchers are conducting studies to understand the drugs’ potential role in treating PCOS, a leading cause of infertility, but companies have yet to systematically study their use for this condition.
TNT’s halftime antics took a funny turn when Charles Barkley revealed he’s using Mounjaro for weight loss, leading to a chorus of advice from the crew. Prior to Game 2, the prank continued with a kale shower and Shaq’s attempted force-feeding, much to Barkley’s dismay.
TikTok will take action against influencers who promote popular weight-loss drugs like Ozempic, Mounjaro, and Wegovy. The platform will prohibit ‘before-and-after’ photos and restrict minors from accessing weight loss content related to medication or extreme practices. The move aims to prevent content that could promote unhealthy weight management behaviors.
